Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (231-240 of 311) with videos related to

Pageof 32
Sort By:
Rheumatology (Oxford, England)|August 12, 2020
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESSRenaud Felten, Margherita Giannini, Benoit Nespola, et al.
Rheumatology (Oxford, England)|September 19, 2020
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndromeMaria Juarez, Nieves Diaz, Geoffrey I Johnston, et al.
Annals of Internal Medicine|April 15, 2014
Treatment of primary Sjögren syndrome with rituximab: a randomized trialValérie Devauchelle-Pensec, Xavier Mariette, Sandrine Jousse-Joulin, et al.
Frontiers in Immunology|June 21, 2018
Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus ErythematosusAnke Rietveld, Luuk L van den Hoogen, Nicola Bizzaro, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|January 26, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022Kevin L Winthrop, John D Isaacs, Philip J Mease, et al.
Human Molecular Genetics|April 6, 2017
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICARaphael Carapito, Jacques-Eric Gottenberg, Irina Kotova, et al.
JAMA|September 20, 2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical TrialValérie Devauchelle-Pensec, Guillermo Carvajal-Alegria, Emmanuelle Dernis, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
Expert Review of Clinical Immunology|December 23, 2015
Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendationsPilar Brito-Zerón, Elke Theander, Chiara Baldini, et al.
Pageof 32

Showing results (231-240 of 311) with videos related to

Sort By:
Pageof 32
Rheumatology (Oxford, England)|August 12, 2020
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESSRenaud Felten, Margherita Giannini, Benoit Nespola, et al.
Rheumatology (Oxford, England)|September 19, 2020
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndromeMaria Juarez, Nieves Diaz, Geoffrey I Johnston, et al.
Annals of Internal Medicine|April 15, 2014
Treatment of primary Sjögren syndrome with rituximab: a randomized trialValérie Devauchelle-Pensec, Xavier Mariette, Sandrine Jousse-Joulin, et al.
Frontiers in Immunology|June 21, 2018
Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus ErythematosusAnke Rietveld, Luuk L van den Hoogen, Nicola Bizzaro, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|January 26, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022Kevin L Winthrop, John D Isaacs, Philip J Mease, et al.
Human Molecular Genetics|April 6, 2017
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICARaphael Carapito, Jacques-Eric Gottenberg, Irina Kotova, et al.
JAMA|September 20, 2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical TrialValérie Devauchelle-Pensec, Guillermo Carvajal-Alegria, Emmanuelle Dernis, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
Expert Review of Clinical Immunology|December 23, 2015
Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendationsPilar Brito-Zerón, Elke Theander, Chiara Baldini, et al.
Pageof 32